The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary outcomes of a prospective observational study of combinatorial abiraterone acetate/enzalutamide (AA/Enz) and radical radiotherapy (RT) in nonmetastatic node-positive (N+M0) prostate cancer (PCa).
 
Mark Ting Le Tan
No Relationships to Disclose
 
Wai Yee Woo
No Relationships to Disclose
 
Jeffrey Tuan
No Relationships to Disclose
 
Terence Wee Kiat Tan
No Relationships to Disclose
 
Michael Lian Chek Wang
No Relationships to Disclose
 
Eu Tiong Chua
No Relationships to Disclose
 
Wen Shen Looi
No Relationships to Disclose
 
Youquan Li
No Relationships to Disclose
 
Wen Long Nei
No Relationships to Disclose
 
Hai-Tao Wang
No Relationships to Disclose
 
Anusha Chimmiri
No Relationships to Disclose
 
Adelene Sim Yen Ling
No Relationships to Disclose
 
Enya Hui Wen Ong
No Relationships to Disclose
 
Li Yan Khor
No Relationships to Disclose
 
Joe Poh Sheng Yeong
No Relationships to Disclose
 
Chien sheng Tan
No Relationships to Disclose
 
Kae-Jack Tay
No Relationships to Disclose
 
Lui Shiong Lee
No Relationships to Disclose
 
Ravindran Kanesvaran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen; MSD Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MSD Oncology; Novartis; pfizer
Research Funding - Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; MSD Oncology
 
Melvin Lee Kiang Chua
Stock and Other Ownership Interests - Varian Medical Systems
Honoraria - AstraZeneca; Ferring; Janssen Oncology; Varian Medical Systems
Consulting or Advisory Role - Astellas Pharma; Illumina; Janssen Oncology
Research Funding - Ferring; GenomeDx; Medlever (Inst); PVmed; Varian Medical Systems
Travel, Accommodations, Expenses - Apollo; Ferring; Varian Medical Systems